Lesions pose significant threat to vision

Lesions pose significant threat to vision

Primitive retinal vascular tumours and telangiectasias can cause significant visual impairment and accurate diagnosis is important in determining which treatment will be most appropriate in any particular case, according to a review of literature carried out by Karl Anders Knutsson MD and associates at the San Raffaele Scientific Institute, Milan, Italy. The authors noted that if these conditions are left untreated, chronic macular oedema and exudation can lead to drastic complications such as retinal detachment and consequent neovascular glaucoma. OCT findings aid the diagnosis of these conditions and offer important information regarding the disease and eventual therapeutic management. The current therapeutic strategies are aimed at reducing lesion growth, amount of exudation and to prevent or resolve complications. They include laser photocoagulation, intravitreal injection of anti-VEGF drugs, cry therapy and PDT.

(Knutsen et al, Ophthalmologica 2012; DOI: 10.1159/000338230.) 

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...